Brain Scientific Inc. (BRSF) Offers Solutions to Flatten COVID-19 Curve
Over one-third of hospitalized individuals are in danger of suffering neurological issues Traditional EEGs present various challenges, including cross-contamination NeuroCap(TM) makes EEGs more accessible, sanitary Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company with two FDA-cleared products, provides next-gen solutions to the neurology market. Neurological care that reduces the opportunity of cross-contamination is critically needed in the effort to combat COVID-19. According to the CDC's national forecast data, the United States is predicted to report a new record of COVID-19 cases, anticipated to number between 1 million and 2.3 million new cases the week ending Jan. 2, 2021 (https://ibn.fm/NveF2). A recent…